how is hers still selling compounded semaglutide Hims & Plan to Sell Knockoff Weight Loss Drug Looking Shaky Hims to stop offering GLP-1
Description
This includes patient education about GLP-1 medications and their mechanisms, potential side effects, and proper administration
Under Section 503A, state-licensed pharmacies can only compound with bulk drug substances that meet specific criteria, such as having a USP/NF monograph, being part of an FDA-approved drug, or being listed on the FDAs 503A bulks list
Foods that one person tolerates may cause issues for another
Health Canada also warned about these risks, as well as the potential for mood swings, blood sugar imbalances, liver or kidney damage, and blood clots
This makes the conversation around GLP-1 medications vs
